A booster shot of the anti-COVID-19 vaccine developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection, according to trial data published by the makers on Thursday.This post was originally published on this site
Vaccination is over 90 percent effective at preventing deaths from the Delta variant of COVID-19, according to the first country-level data on mortality.This post was originally published on this site
U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from […]
© 2021 EarnWithSocial.ca - Canada's Technology News and Highlights | Read. Learn. Share.